SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000899923-21-000090
Filing Date
2021-11-04
Accepted
2021-11-04 16:04:55
Documents
88
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mygn-20210930.htm   iXBRL 10-Q 1787047
2 EX-10.1 exhibit101-amendedandresta.htm EX-10.1 91195
3 EX-31.1 exhibit311-certificationof.htm EX-31.1 10543
4 EX-31.2 exhibit312-certificationof.htm EX-31.2 10559
5 EX-32.1 exhibit321-certificationpu.htm EX-32.1 6388
  Complete submission text file 0000899923-21-000090.txt   8539624

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mygn-20210930.xsd EX-101.SCH 50378
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mygn-20210930_cal.xml EX-101.CAL 90293
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mygn-20210930_def.xml EX-101.DEF 242265
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mygn-20210930_lab.xml EX-101.LAB 660399
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mygn-20210930_pre.xml EX-101.PRE 426973
11 EXTRACTED XBRL INSTANCE DOCUMENT mygn-20210930_htm.xml XML 1660295
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26642 | Film No.: 211379864
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences